SCHEMBL24968231

SCHEMBL24968231

COc1ncc(CC=O)cc1C(F)(F)F

nearest known ligand 0.37

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AURKA O14965 1/20 0.37
KDR P35968 1/20 0.37
AURKB Q96GD4 1/20 0.37
CFTR P13569 3/20 0.33
MAPT P10636 1/20 0.33
LMNA P02545 1/20 0.33
NFE2L2 Q16236 2/20 0.33
AR P10275 1/20 0.32
KDM4E B2RXH2 1/20 0.32
GLA P06280 1/20 0.32
CYP11B1 P15538 1/20 0.32
CYP11B2 P19099 1/20 0.32
PIK3CD O00329 5/20 0.32
PIK3CA P42336 4/20 0.32
PIK3CB P42338 3/20 0.32
PIK3CG P48736 2/20 0.32
KCNH2 Q12809 1/20 0.32
PIK3R1 P27986 1/20 0.32
MRGPRX4 Q96LA9 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30851258 1.00 AURKA (0.37) AURKAKDRAURKBCFTRMAPT
SCHEMBL27233748 0.88 AURKA (0.37) AURKAKDRAURKBCFTRMAPT
SCHEMBL21031170 0.82 AURKA (0.40) AURKAKDRAURKBCFTRMAPT
SCHEMBL30776172 0.81 AURKA (0.39) AURKAKDRAURKBCFTRMAPT
SCHEMBL27233788 0.81 AURKA (0.39) AURKAKDRAURKBCFTRMAPT
SCHEMBL29208803 0.81 AURKA (0.39) AURKAKDRAURKBCFTRMAPT
SCHEMBL932942 0.81 AURKA (0.39) AURKAKDRAURKBCFTRMAPT
SCHEMBL30851110 0.79 LMNA (0.39) AURKAKDRAURKBCFTRMAPT
SCHEMBL24967935 0.79 SMN1; SMN2 (0.47) LMNACYP11B1CYP11B2
SCHEMBL30851253 0.79 SMN1; SMN2 (0.47) LMNACYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117642393-A Novel PARP7 inhibitor and application thereof 上海齐鲁制药研究中心有限公司 2024-03-01 CN disclosed
WO-2023006013-A1 NOVEL PARP7 INHIBITOR AND USE THEREOF 上海齐鲁制药研究中心有限公司 2023-02-02 WO disclosed